Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

Clinical trial NCT01326845 · TERMINATED

Trial details

NCT number: NCT01326845
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Transfusional Iron Overload

Start date: 2011-12-01
Primary completion: 2012-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.